Rapidly progressive phenotype of Lafora disease associated with a novel NHLRC1 mutation

Pediatr Neurol. 2011 Jun;44(6):475-7. doi: 10.1016/j.pediatrneurol.2011.01.012.

Abstract

Lafora disease is a fatal, autosomal recessive form of progressive myoclonus epilepsy. Patients characteristically exhibit myoclonic and tonic-clonic seizures and cognitive impairment, beginning in their second decade. Alterations in two genes were identified as the cause of the disease. Mutations in the NHL repeat containing 1 (NHLRC1) gene were described in association with a more benign clinical course and later age of death, compared with epilepsy progressive myoclonus type 2A (EPM2A) mutations. We describe a rapidly progressive phenotype of Lafora disease in an adolescent patient with a novel NHLRC1 mutation. He developed severe disability and dementia less than 2 years after the onset of signs.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Carrier Proteins / genetics*
  • Disease Progression*
  • Humans
  • Lafora Disease / genetics*
  • Lafora Disease / pathology
  • Male
  • Mutation / genetics*
  • Phenotype*
  • Time Factors
  • Ubiquitin-Protein Ligases

Substances

  • Carrier Proteins
  • NHLRC1 protein, human
  • Ubiquitin-Protein Ligases